Karin Jooss is of Gritstone bio, Inc.. Currently has a direct ownership of 683,526 shares of GRTS, which is worth approximately $20,505. The most recent transaction as insider was on May 16, 2024, when has been sold 13,749 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $10,311. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 684K
0% 3M change
8.47% 12M change
Total Value Held $20,505

Karin Jooss Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
SELL
Open market or private sale
$10,311 $0.75 p/Share
13,749 Reduced 1.97%
683,526 Common Stock
May 15 2024
BUY
Grant, award, or other acquisition
-
27,128 Added 3.74%
697,275 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 5.81%
648,851 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
252,763 Added 28.63%
630,147 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
27,600 Added 6.82%
377,384 Common Stock
Jan 07 2021
BUY
Grant, award, or other acquisition
-
27,900 Added 7.39%
349,784 Common Stock

Also insider at

FATE
FATE THERAPEUTICS INC Healthcare
KJ

Karin Jooss

San Diego, CA

Track Institutional and Insider Activities on GRTS

Follow Gritstone bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRTS shares.

Notify only if

Insider Trading

Get notified when an Gritstone Bio, Inc. insider buys or sells GRTS shares.

Notify only if

News

Receive news related to Gritstone bio, Inc.

Track Activities on GRTS